D-0074-2027 Class II Ongoing
FDA drug recall D-0074-2027 was initiated by Glenmark Pharmaceuticals Inc., USA on Oct 9, 2026 and is designated Class II. Reason for recall: Labeling: Not Elsewhere Classified The recall status is ongoing. Affected quantity: 1296 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 4, 2026
- Initiation Date
- Oct 9, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1296 bottles
Product description
Abiraterone Acetate Tablets USP 500 mg, 60-count bottles, Rx only, Distributed by: Glenmark Pharmaceuticals USA, Elmwood Park, NJ 07407, NDC 68462-882-60
Reason for recall
Labeling: Not Elsewhere Classified
Distribution pattern
Nationwide within the United States
Code information
Lot #: 13250135, Exp. Date 11/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0074-2027
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026